Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The gradual deterioration of cognitive functions in Alzheimer's disease is paralleled by a hierarchical progression of amyloid-beta and tau brain pathology. Recent findings indicate that toxic oligomers of amyloid-beta may cause propagation of pathology in a prion-like manner, although the underlying mechanisms are incompletely understood. Here we show that small extracellular vesicles, exosomes, from Alzheimer patients' brains contain increased levels of amyloid-beta oligomers and can act as vehicles for the neuron-to-neuron transfer of such toxic species in recipient neurons in culture. Moreover, blocking the formation, secretion or uptake of exosomes was found to reduce both the spread of oligomers and the related toxicity. Taken together, our results imply that exosomes are centrally involved in Alzheimer's disease and that they could serve as targets for development of new diagnostic and therapeutic principles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, in damaged environments, like AD, exosomes are involved in the transportation of damaging proteins like Aβ and Tau [116].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [116]
The cited source says what the claim attributes to it.
In the citing paper
“A previous study has shown that sEVs isolated from the brains of AD patients contain elevated levels of Aβ oligomers [141].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [141]
The cited source says what the claim attributes to it.
In the citing paper
“These EVs have been discovered as possible transporters for transferring toxic protein species from neuron to neuron, as has been shown in vitro.”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [141]
The cited source says what the claim attributes to it.
In the citing paper
“oAβ42 has been detected within neuronal exosomes.”
From The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein Aggregates (2020) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“Data from cells treated with these exosomes also revealed that the exosomes facilitated delivery of oAβ42 and induced toxic effects [24].”
From The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein Aggregates (2020) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ngolab, J., Trinh, I., Rockenstein, E., Mante, M., Florio, J., Trejo, M., Masliah, D., Adame, A., Masliah, E., & Rissman, R. A. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0445-5 · Cited by 200 · cited 1×
“These findings suggest that exosomes might be the main mediator of the pathogenic progression in AD as was recently suggested for dementia with Lewy bodies [41].”
BackgroundRetractedNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Exosomes: composition, biogenesis and function
Théry, C., Zitvogel, L., & Amigorena, S. (2002) · Nature Reviews Immunology · doi:10.1038/nri855 · Cited by 5,346 · cited 2×
“It has been suggested that exosomal release may provide an alternative disposal mechanism to lysosomal degradation of oAβ [5] or other proteins that are resistant to degradation [55].”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“The nature of the propagating species has not been established, although several studies have indicated a particularly pathogenic role of soluble oAβ on synaptic and cellular functions and structure [13, 32, 50, 60].”
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591 · cited 1×
“1 3 Aß, tau and α-synuclein [12, 17, 46, 59] and can propagate tau pathology [4].”
BackgroundAlzheimer’s disease β-amyloid peptides are released in association with exosomes
Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., & Simons, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603838103 · Cited by 1,343 · cited 2×
“Accordingly, exosomes from blood [22], CSF [17, 49] and cell cultures [46] have been shown to contain monomeric Aβ and tau, but so far, no study has addressed the presence of oAβ in exosomes from human AD brains.”
BackgroundAxonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214 · cited 1×
“Here dystrophic neurites with neurite beading and loss of neurite branching were identified, known early signs of neurodegeneration [51].”
Background
Research works printed but not linked: 1
- Tucker S, Möller C, Tegerstedt K, Lord A, Laudon H, Sjödahl J, Söderberg L, Spens E, Sahlin C, Waara ER et al (2015) The murine version of BAN2401 (mAb158) selectively reduces amyloid-β protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice. JAD 43:575–588. https://doi.org/10.3233/JAD-140741 · DOI · Paper page
Cited by
Items 401–500 of 529
Phan, N. D., Sharma, R. R., Subramanian, S., & Kartha, R. V. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1813553 · Cited by 4
“In AD, EVs isolated from CSF or blood have been reported to contain amyloid-beta (A β ) and tau species, while in PD, α -synuclein–associated EV populations have shown associations with disease state or severity in selected cohorts (Yan et al., 2024; Wang X. et al., 2024; Sinha et al., 2018).”
Indirubin Inhibits TRAIL-Induced Activation of Death Receptor 5 in Jurkat Cells
Young, M. C., Vunnam, N., Rebbeck, R. T., Yuen, S. L., Thomas, D. D., & Sachs, J. N. (2023) · Natural Product Communications · doi:10.1177/1934578x221144580 · Cited by 4
“Donor-only (DR5ΔCD-GFP) was transfected at 2.5 ug.”
MethodInfluentialExploring exosomes to provide evidence for the treatment and prediction of Alzheimer’s disease
QUAN, X., MA, X., LI, G., FU, X., LI, J., & ZENG, L. (2023) · Biocell · doi:10.32604/biocell.2023.031226 · Cited by 4
Xing, X., Liu, H., Zhang, M., & Li, Y. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1485750 · Cited by 5
Adnan, M., Siddiqui, A. J., Bardakçi, F., Surti, M., Badraoui, R., & Patel, M. B. (2025) · Pharmaceuticals · doi:10.3390/ph18060921 · Cited by 4
“Studies have shown that EVs can carry aggregated forms of A β , which can induce neurotoxic effects in recipient neurons [60,61].”
Walsh, R. B., Becalska, A. N., Zunitch, M. J., Lemos, T., Dresselhaus, E. C., Lee, S. M., Wang, S., Isaac, B., Yeh, A., Koles, K., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/645713 · Cited by 4
“APP C-terminal fragments and Aβ have been found in pathogenic EVs (Laulagnier et al., 2017; Perez-Gonzalez et al., 2012; Rajendran et al., 2006; Sardar Sinha et al., 2018; Sharples et al., 2008), but the mechanisms by which APP is sorted into EVs are not well understood, and are challenging to study in vivo at synapse…”
Chiasserini, D., Bijnsdorp, I. V., Bellomo, G., Orvietani, P. L., Piersma, S. R., Pham, T. V., Parnetti, L., & Jiménez, C. R. (2020) · medRxiv · doi:10.1101/2020.02.22.20026609 · Cited by 5
Maladies neurodégénératives et stress oxydant
Lévy, E. (2020) · theses.fr (ABES) · doi:10.70675/75371581z194fz4cb4zb457z91bf72dc0320 · Cited by 4
Liu, Y. N., Liu, S., Yan, B., Yin, Z., Liao, P., Wang, Y., Li, D., Han, Z., Zhang, S., Ge, X., et al. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112931 · Cited by 4
Future horizons: Innovation, aging, and equity
Jana, M. K., Swarup, V., Mukherjee, P., Tripathy, S., Gupta, N. M., Sutheertha, C. S., Joshi, D., Mandal, S., Giri, A., Jana, S., et al. (2025) · Progress in brain research · doi:10.1016/bs.pbr.2025.08.010 · Cited by 3
A Question of Origins: Non-neuronal Sources of Amyloid-β
Sasmita, A. O., & Depp, C. (2026) · Neuroscience Bulletin · doi:10.1007/s12264-025-01572-4 · Cited by 5
“Aside from permitting release of Aβ with implications for its clearance and extracellular plaque deposition [60], exosomes can mediate the propagation of Aβ between neural cells [62].”
Autophagy–exosome crosstalk in neurodegeneration: Mechanisms and therapeutic opportunities
Sedighi, S., Guan, T., Michetti, F., Cordani, M., Behrooz, A. B., Sabouni, F., Eshraghi, M., Saleem, A., Ghavami, S., & Aghanoori, M. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109025 · Cited by 3
Zhu, Y., Zhao, L., Li, Y., Tian, M., Liao, Y., Huang, J.-L., Guo, P., & Xie, Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073089 · Cited by 3
Extracellular vesicle therapeutics in Alzheimer’s disease: mechanisms, progress, and prospects
Fang, Y., Hao, X., & Fang, B. (2026) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2025.158 · Cited by 3
Izquierdo‐Altarejos, P., & Felipo, V. (2024) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2023.66 · Cited by 4
Ercin, N., Beşli, N., Johnson, B. S., Cakmak, R. K., Beker, M., Beker, M. Ç., & Kılıç, Ü. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04908-3 · Cited by 6
“In another study, it was stated that exosomes isolated from AD patients contained amyloid-β, and using SH-SY5Y cells, it was reported that amyloid-β spread through exosomes and that in vitro toxicity could be reduced by blocking exosome formation, secretion, or uptake [43].”
Quattrini, G., Gatti, E., Peretti, D. E., Aiello, M., Chevalier, C., Lathuilière, A., Park, R., Pievani, M., Salvatore, M., Scheffler, M., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07299-8 · Cited by 4
Mattson, M. P. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.09.001 · Cited by 3
Subcellular proteomics insights into Alzheimer's disease development
Liang, Z., Zhuang, H., Cao, X., Ma, G., & Shen, L. (2023) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.202200112 · Cited by 3
The Roles and Mechanisms of EVs in Disease Processes
Liu, T. (2024) · Springer eBooks · doi:10.1007/978-981-99-8365-0_5 · Cited by 3
Les vésicules extracellulaires: Actrices de la communication entre les cellules du système nerveux
Leroux, É., Perbet, R., Buée, L., & Colin, M. (2021) · médecine/sciences · doi:10.1051/medsci/2021205 · Cited by 5
Shi, Y., Bao, Q., Chen, W., Wang, L., Peng, D., Liu, J., Liu, Q., Zhang, Y., Ji, Z., & Shen, A. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215666 · Cited by 3
Danna, R., Kondle, S., Amar, O., Mabourakh, M., Chen, G., Fadol, W. B., & Mohieldin, A. M. (2025) · Biology · doi:10.3390/biology14121787 · Cited by 2
“However, in damaged environments, like AD, exosomes are involved in the transportation of damaging proteins like A β and Tau [116].”
Jiang, B., Guan, J., Lv, Y., Yang, C., Yang, M., Shen, X., Xu, B., Wang, Q., Qin, Y., & Wu, L. J. (2025) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2025.138511 · Cited by 3
Tiny Messengers, Huge Consequences: Extracellular Vesicles and mTOR Signaling in Neuroinflammation
Garcia‐Segura, P., Chicote‐González, A., Espasa‐Marco, A., Garcia‐Alcaraz, M., Mora‐Bernabé, L., Abelló‐Fernández, M., & Malagelada, C. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70256 · Cited by 2
“Indeed, EVs can induce aggregation of these proteins and propagate their pathology to neurons in vitro (Sardar Sinha et al. 2018) and in vivo (Elsherbini et al. 2020).”
The Cerebral Clearance Cascade as a Driver of Alzheimer’s Disease Progression
Izrael, M., & Frenkel, O. M. (2025) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad3010001 · Cited by 2
“Hence, cerebral waste disposal should be considered a dual-mode system combining solute clearance through perivascular/glymphatic routes and vesicular trafficking through exosomes and other EVs [115].”
HOPS disruption impairs APP trafficking and processing, promoting exosomal secretion of APP-CTFs
Draper, D., George, A. E., Veenendaal, T., van Dijk, S., Soltani, E., Sanzà, P., Verweij, F. J., Klumperman, J., & Farías, G. G. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107269 · Cited by 3
Extracellular vesicles in Niemann pick disease type C: current knowledge and future opportunities
Hawthorne, S. C. B., Sandau, U. S., & Saugstad, J. A. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1730603 · Cited by 2
Sharma, R., Song, B. S., Rane, R., Paul, D., Singh, B., Verma, T., Mishra, A., Karan, A., & Song, J. J. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119297 · Cited by 3
Xin, J., Liu, J., Dong, H.-M., Yu, H., Xiao, Z., Hu, J.-N., Jiang, Q., Zhu, Y.-P., Feng, L., Feng, Y., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3243-2 · Cited by 2
“These EVs facilitate the propagation of pathogenic molecules across synapses, contributing to their spreading throughout the brain (Leroux et al., 2022; Ruan et al., 2021; Sardar Sinha et al., 2018).”
Defective regulated secretion: A trigger for Alzheimer’s pathology?
Verma, B., Singh, P., Goberdhan, D. C. I., & WILSON, C. G. (2026) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2026.102926 · Cited by 2
Yadav, B., Gangwar, P., Kumari, K., Yadav, A., Rao, R., Kumar, K., Verma, H., Dhiman, M., & Mantha, A. K. (2026) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2026.1835778 · Cited by 3
“Collectively, these findings establish, exosome-mediated intracellular delivery and propagation of A β represent a central pathway driving AD progression (Sinha et al., 2018).”
Ali, S., Mukherjee, S., Goel, D., Ghosh, A., & Faruq, M. (2023) · Springer eBooks · doi:10.1007/978-981-99-3848-3_10 · Cited by 2
A Review on Alzheimer’s disease and mesenchymal stem cell therapy
Ullah, A., Abbasi, S. H., Badshah, I., Latif, K., Mateen, A., Aslam, A., Rehman, N. U., Anwar, M., Bhutta, A. H., & Khan, M. I. (2022) · Journal of Shifa Tameer-e-Millat University · doi:10.32593/jstmu/vol5.iss1.190 · Cited by 2
Artificial Exosomes as Targeted Drug Delivery Systems
Tsakiri, M., Naziris, N., Mahairaki, V., & Demetzos, C. (2022) · Nanotechnology in the life sciences · doi:10.1007/978-3-031-12658-1_5 · Cited by 3
Auderset, L., & Antoniou, A. (2023) · Trillium Extracellular Vesicles · doi:10.47184/tev.2023.01.03 · Cited by 2
Lipid Metabolism: Key Determinant in Neurodegenerative Diseases
Yadav, M., Gupta, J., & Agrawal, N. (2024) · Springer eBooks · doi:10.1007/978-981-97-4288-2_6 · Cited by 2
Valle‐Tamayo, N., Aranha, M. R., Pérez‐González, R., Serrano‐Requena, S., Videla, L., Barroeta, I., Benejam, B., Chiva‐Blanch, G., Jiménez, A., Busciglio, J. A., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70137 · Cited by 2
“15,23,24 Therefore,EVsisolatedfrombloodareemergingasanon-invasive tool for biomarker research across a range of diseases.”
Fluid biomarkers for Alzheimer's disease in Down syndrome: Current status and novel trends
Iulita, M. F., Granholm, A., Carmona‐Iragui, M., Hamlett, E. D., Fortea, J., & Ledreux, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818845-3.00010-4 · Cited by 3
Chun, C., Smith, A. S. T., Bothwell, M. A., & Mack, D. L. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91388 · Cited by 2
“For example, exosomes facilitate the intercellular delivery of amyloid beta (Aβ) peptides in Alzheimer’s disease, leading to plaque formation in the recipient cells [19, 20].”
BackgroundD’Arrigo, D., Lässer, C., Urzì, O., Park, K., Bagge, R. O., Lötvall, J. O., & Crescitelli, R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.03.587936 · Cited by 3
García-Contreras, M., Lima, C., Alsop, E. B., Kaszala, B., Meechoovet, B., Purnell, B. A., Jiang, N., Saftics, A., Tang, C., Walsh, O. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.30.684535 · Cited by 2
Analysis of miRNA expression profiles in exosomes of SMB-S15 cells treated with resveratrol
Shi, Q., Zhang, L., Wulayin, X., Cao, R., Jiao, M., Wang, J., Han, J., Dong, X., & Gao, C. (2023) · Archives of Virology · doi:10.1007/s00705-023-05884-6 · Cited by 1
Tian, M., Yi, S., Zhao, L., Li, L., Fang, L., & Ru, Q. (2025) · Pharmacological Research - Reports · doi:10.1016/j.prerep.2025.100035 · Cited by 1
Hernández, S., Valladares‐Rodríguez, S., Novo, M., & Al‐Soufi, W. (2025) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad2040038 · Cited by 2
“Recent evidence indicates that a subset of extracellular A β —particularly A β 42—is selectively packaged into exosomes, the small vesicles derived from endosomes involved in intercellular communication [45,46].”
Extracellular exosome signature links hypertension and Alzheimer’s disease
Bastrup, J., Folke, J., Kaalund, S. S., Rasmussen, M., Aznar, S., & Jepps, T. A. (2026) · GeroScience · doi:10.1007/s11357-026-02097-y · Cited by 1
“Exosomes are 30–150 nm sized vesicles encasing e.g. proteins, cytokines and miRNA [41].”
Research progress on biomarkers of traumatic brain injury
Shen, X., Cheng, S., Chen, S., Wang, M., Li, T., Xu, W., Zhang, Y., Yuan, P., & Shi, L. (2026) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70173 · Cited by 1
Vibrational spectroscopy as a complementary approach to monitor SH-SY5Y cell differentiation
Almeida, I., Martins, F., Goodfellow, B. J., Rebelo, S., & Nunes, A. (2026) · Analytical Biochemistry · doi:10.1016/j.ab.2026.116139 · Cited by 1
Zhang, Q., Li, Y., Li, Y., Han, L., Yan, J., Zhan, M., Liu, T., Ke, P., Wang, Q., & Huang, X. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.6795217 · Cited by 1
Guleria, V. S., & Winston, C. N. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71645 · Cited by 1
Exosome Biology at the Interface of Neurodegeneration and Therapeutic Innovation
Maity, D., Gowtham, A., Mishra, Y., & Kaundal, R. K. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06052-y · Cited by 2
“2) [48, 49].”
LaRocca, T. J., & LaRocca, T. J. (2024) · Physiology · doi:10.1152/physiol.2024.39.s1.2598 · Cited by 1
Fan, X., Ye, X., Xu, J., Mao, T., Zhang, R., Zhou, X., Yeung, C. C. K. A., Li, C., Chang, R. C., Lin, H., et al. (2025) · Advanced Science · doi:10.1002/advs.202509376 · Cited by 3
Part Two: Extracellular Vesicles as a Risk Factor in Neurodegenerative Diseases
Ceafalan, L. C., Ioghen, O. C., Marta, D. S., Constantin, A. L., Alexandru, N., Nemecz, M., Tanko, G., Filippi, A., Magda, S. L., Bojin, F. M., et al. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.86604 · Cited by 1
Role of PAR-4 in Ceramide-Inducible Effects in Neurodegeneration
Elsherbini, A. M., & Bieberich, E. (2021) · Springer eBooks · doi:10.1007/978-3-030-80558-6_13 · Cited by 2
Miyahara, H., Dai, J., Li, Y., Cui, X., Takeuchi, H., Hachiya, N., Kametani, F., Yazaki, M., Mori, M., & Higuchi, K. (2022) · Amyloid · doi:10.1080/13506129.2022.2153667 · Cited by 1
he, X., Zhou, X., Zhang, L., Wang, N., Niu, X., Zou, C., Li, Y., Wang, L., & Wang, X. (2022) · Research Square · doi:10.21203/rs.3.rs-1566317/v1 · Cited by 1
Investigation of the intercellular transmission of α-synuclein, amyloid-β and TDP-43
Sackmann, C. (2019) · Linköping University medical dissertations · doi:10.3384/diss.diva-160318
The Propagation of Neurodegenerative Diseases by Inflammation and Exosomes
Sackmann, V. (2019) · Linköping University medical dissertations · doi:10.3384/diss.diva-160949 · Cited by 1
“19 AD brains contain an elevated amount of oAβ [26].”
BackgroundMethodInfluentialPolymorphic protein aggregation in tauopathies
Sandberg, A. (2019) · Linköping studies in science and technology. Dissertations · doi:10.3384/diss.diva-161659
“A oligomers have been shown to be able to spread through exosomes [52].”
BackgroundExosomes in Neurodegenerative Disorders
Elmehrath, A. O., Sonbol, Y. T., & Farghal, M. Y. (2020) · Springer eBooks · doi:10.1007/978-981-15-6599-1_8
6-gingerol interferes with amyloid-beta (Aβ) peptide aggregation
Berntsson, E., Paul, S., Jarvet, J., Vosough, F., Barth, A., Gräslund, A., & Wärmländer, S. K. T. S. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153980
The Synaptic RNAome - identification, interactions and intercellular transfer
Epple, R. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8506
Russell, A. E. (2019) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.3947
Binding of Monomeric and Polymeric Alzheimer’s Aβ peptides to ExosomesPreprint
Coughlan, C. M., Lindenberger, J. J., Jacot, J. G., Johnson, N., Anton, P. E., Bevers, S. G., Graner, M. W., & Potter, H. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.06.455470
Strain-specific profiling of Amyloid-β in Alzheimer´s disease: functional and clinical signature
Noor, A. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7997
Complete remissions in chemotherapy of lung cancer models induced in mice by asbestos.
Smith, W. E., Hubert, D. D., Yazdi, E., Holiat, S. M., Bissell, E. C., Watts, L. M., Baylouny, R. A., & Sobel, H. J. (2005) · PubMed
Nielsen, J. E. (2021) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau455017331
Exosomes as mediators of chemical-induced toxicity
Polaka, S., Tekade, M., Vasdev, N., Gupta, T., Pawar, B., Safavi, M., & Tekade, R. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15840-7.00007-5
Exogenous factors that impact huntingtin aggregation
Skeens, A. (2023) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.11933 · Cited by 1
Biotechnological Importance of Exosomes
Bakar, E., Erim, Z., & Türker, N. P. (2023) · Recent advances in biotechnology · doi:10.2174/9789815179422123080008
Research Progress of Neurogenic Exosomes in the Treatment of Alzheimer’s Disease
黄, 思. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1492563 · Cited by 1
Diagnostic potential and biomarkers potential of exosome nanovesicles
Tryphena, K. P., Shukla, R., Goswami, P. G., Renuka, P., & Khatri, D. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-29052-7.00010-6
Exosomes for Ophthalmic Therapeutics
Tao, H., & Li, Z. (2012) · Springer eBooks · doi:10.1007/978-981-97-5536-3_10
Eysert, F., Legros, V., Gay, A.-S., Debayle, D., Lacas‐Gervais, S., Chevreux, G., Bottlaender, M., Dorothée, G., Checler, F., Potier, M.-C., et al. (2025) · Research Square · doi:10.1101/2025.01.08.631851
A comprehensive view of the molecular features within the serum and serum EV of Alzheimer's disease
Zhang, J., Cheng, X., Hu, A., Zhang, X., Zhang, M., Zhang, L., Dai, J., Yan, G., Shen, H., & Fei, G. (2025) · The Analyst · doi:10.1039/d4an01018c
Extracellular vesicles as biomarker and therapeutic targets for neurological disorders
Razi, U., Ahmad, F., Karan, A., Sundar, V., & DeCoster, M. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23891-8.00007-x
López-Cepeda, M. L., Angarita-Rodríguez, A., Rojas-Cruz, A. F., Mejia, J. P., Khatri, R., Brehler, M., Martínez‐Martínez, E., Pinzón, A. M., Aristizábal-Pachón, A. F., & González, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083544
“However, prior research largely focused on the protein cargo within NDEVs, particularly amyloid-β (A β ) peptides [14,17,34].”
Walker, W. P., Ratz-Mitchem, M. L., Wagner, K., & Gunn, T. M. (2025) · Biomolecules · doi:10.3390/biom15060786
Exosome Isolation from Brain Tissue of the 3xTgAD Mouse Model for Alzheimer's Disease
Jaques, S. (2025) · Digital Commons - DU (University of Denver) · doi:10.56902/etdcrp.2025.46
GSDME unlocks astrocyte-driven neurotoxicity in Alzheimer’s DiseasePreprint
Xie, X., Ji, C., Xu, J., Lu, X., Guo, G., Wu, X., Liu, W., Chen, Y., Zhang, Y., Wang, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.28.672784
Extracellular vesicles-enclosed biomolecules as silent messengers in human pathologies
Fagoonee, S. (2025) · Minerva Biotechnology and Biomolecular Research · doi:10.23736/s2724-542x.25.03307-3
Exosomes as a Double-Edged Sword in Neurodegenerative Diseases: Roles and Engineering Strategies
Liu, R. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2025.au27718
Aβ Modulates Extracellular Vesicles Proteomic Profile Impacting Phosphorylation Mediators
Vaz, M., Martins, T. S., Trigo, D., Silva, O. A. B. D. C. E., Amado, F. M. L., Vitorino, R. M. P., & Henriques, A. G. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05343-0 · Cited by 1
“For instance, neuronal EVs can either contribute to the spread of Aβ and tau to other neurons, exacerbating cytotoxicity [26, 29], or promote the fibrilization of Aβ into non-toxic amyloid forms, serving as a protective mechanism [54].”
Ali, T., Klein, A. N., McDonald, K., Johansson, L. E., Mukherjee, P. G., Hallbeck, M., Doh‐ura, K., Schatzl, H. M., & Gilch, S. (2024) · Figshare · doi:10.6084/m9.figshare.26607130
Self-citationZhao, A., Li, Y., Yan, Y., Qiu, Y., Li, B., Xu, W., Wang, Y., Liu, J., & Deng, Y. (2020) · Figshare · doi:10.6084/m9.figshare.12752228
Singh, R., Rai, S., Bharti, P. S., Zehra, S., Gorai, P. K., Modi, G. P., Rani, N., Dev, K., Inampudi, K. K., Y., V. V., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26736822
Cano, A., Antonio, E. E., Bernuz, M., Puerta, R., García‐González, P., de Rojas, I., Olivé, C., Pérez‐Cordón, A., Montrreal, L., Núñez‐Llaves, R., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22607779
Gallart-Palau, X., Guo, X., Serra, A., & Sze, S. K. (2020) · Figshare · doi:10.6084/m9.figshare.12276845
Vandendriessche, C., Balusu, S., Cauwenberghe, C. V., Brkic, M., Pauwels, M. J., Plehiers, N., Bruggeman, A., Dujardin, P., Imschoot, G. V., Wonterghem, E. V., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16417667
Zhang, L., Yao, Q., Hu, J., Qiu, B., Xiao, Y., Zhang, Q., Zeng, Y., Zheng, S., Zhang, Y., Wan, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26672235
Li, X., Di, B., Niu, J., & Hou, H. (2026) · Journal of the Chinese Chemical Society · doi:10.1002/jccs.70132
Crossing the blood–brain barrier: exosomes in neurological research
Prakāsh, C., Saran, S., & Sharma, D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36390-0.00019-1
Extracellular Vesicles in Neurodegenerative Diseases: Tools for Therapy and Regeneration
Bakr, M., Gobba, F., Sabry, M., & Salama, M. (2026) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-032-12705-1_3
Netrin-1 in extracellular vesicles : a new secretory pathway
Fiore, S. (2019) · theses.fr (ABES) · doi:10.70675/d67eb9cdz25f4z4d1czbf7czf70e76f70396
Hunter, T., Silva, N. M. L. E., de Freitas, G. B., Rody, T., Santos, L. E., Zhang, J., Bullock, A., Tartaglia, M. C., Abraham, S. A., Nicolini, C., et al. (2026) · Brain Communications · doi:10.1093/braincomms/fcag085
“43,44 However, the exact role of EVs in ageing remains to be determined.”
Les vésicules extracellulaires : un outil de choix pour l'étude des protéines membranaires
Delauzun, V. (2020) · theses.fr (ABES) · doi:10.70675/7bb2f7cdze68az405ezb197z218501afa4f4
Metadata
- Authors
- Sardar Sinha, M., Ansell-Schultz, A., Civitelli, L., Hildesjö, C., Larsson, M., Lannfelt, L., Ingelsson, M., & Hallbeck, M.
- Affiliations
- Linköping University (SE)
- Uppsala University (SE)
- Corresponding author
- Hallbeck, Martin
- Venue
- Acta Neuropathologica
- Published
- 2018-06-13
- Volume
- 136
- Issue
- 1
- Pages
- 41-56
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC6015111
- OpenAlex
- W2807776100
- Cited by
- 527
- References
- 60
- Citations by year
- 2026: 48 · 2025: 70 · 2024: 71 · 2023: 64 · 2022: 60 · 2021: 74 · 2020: 82 · 2019: 50 · 2018: 6
- FWCI
- 36.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- Funders
- Vetenskapsrådet (523-2013-2735)
- Alzheimerfonden
- Hjärnfonden
- Hans-Gabriel och Alice Trolle Wachtmeister Stiftelse för Medicinsk forskning
- Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
- Knut och Alice Wallenbergs Stiftelse
- Demensförbundet
- Linköpings Universitet
- Region Östergötland
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, exosomes, amyloid-beta oligomers, prion-like propagation, extracellular vesicles, tau pathology, exosome secretion, exosome uptake, neurotoxicity
- MeSH terms
- Tsg101 Protein, Aged, Aged, 80 and over, Alzheimer Disease, Brain, Cell Line, Transformed, DNA-Binding Proteins, Female, Gene Expression Regulation, Humans, L-Lactate Dehydrogenase, Male, Membrane Proteins, Middle Aged, Neuroblastoma, Organic Chemicals, Peptide Fragments, Transcription Factors, Amyloid beta-Peptides, Culture Media, Conditioned, Coculture Techniques, Protein Transport, Pluripotent Stem Cells, Microscopy, Electron, Transmission, Exosomes, Endosomal Sorting Complexes Required for Transport
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.